Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
Inhibrx Biosciences, Inc
Inhibrx Biosciences, Inc
Columbia University
BeiGene
University of California, San Francisco
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)